These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 499995)

  • 1. Response of plasma somatostatin-like immunoreactivity to the administration of alloxan in dogs.
    Schusdziarra V; Harris V; Unger R
    Horm Metab Res; 1979 Aug; 11(8):457-9. PubMed ID: 499995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and effects of intravenous infusion of somatostatin in normal subjects--a two-compartment open model.
    Ho LT; Chen RL; Chou TY; Fong JC; Wang PS; Chou CK
    Clin Physiol Biochem; 1986; 4(4):257-67. PubMed ID: 2875821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
    Berelowitz M; Kronheim S; Pimstone B; Shapiro B
    J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of extrapancreatic immunoreactive glucagon to intraluminal nutrients in pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Jul; 16(7):344-8. PubMed ID: 6386643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin.
    Matsuyama T; Wider MD; Tanaka R; Shima K; Tarui S; Nishikawa M; Foà PP
    Diabete Metab; 1979 Jun; 5(2):141-7. PubMed ID: 478084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma glucagon and insulin in rat pregnancy. Roles in glucose homeostasis.
    Saudek CD; Finkowski M; Knopp RH
    J Clin Invest; 1975 Jan; 55(1):180-7. PubMed ID: 1109177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.
    Wasada T; Howard B; Dobbs RE; Unger RH
    J Clin Invest; 1980 Sep; 66(3):511-6. PubMed ID: 6105166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of glucagon in mediating epinephrine-induced hyperglycemia in alloxan-diabetic dogs.
    Perez G; Kemmer FW; Lickley HL; Vranic M
    Am J Physiol; 1981 Oct; 241(4):E328-35. PubMed ID: 7032319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.
    Schusdziarra V; Harris V; Conlon JM; Arimura A; Unger R
    J Clin Invest; 1978 Sep; 62(3):509-18. PubMed ID: 690183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin of peripheral venous hypersomatostatinemia in alloxan-diabetic dogs.
    Schusdziarra V; Rouiller D; Harris V; Unger RH
    Endocrinology; 1981 Oct; 109(4):1107-16. PubMed ID: 6116595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Route of administration as a factor in the selectivity of hormone suppression of a somatostatin analog in rats.
    Lien EL; Garsky VM
    Horm Metab Res; 1981 Dec; 13(12):675-8. PubMed ID: 6119282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of somatostatin-like immunoreactivity from the lower gut.
    Rouiller D; Schusdziarra V; Conlon JM; Harris V; Unger RH
    Gastroenterology; 1979 Oct; 77(4 Pt 1):700-3. PubMed ID: 467926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of E coli endotoxin on pancreatic hormones and blood flow.
    Spitzer JJ; Ferguson JL; Hirsch HJ; Loo S; Gabbay KH
    Circ Shock; 1980; 7(4):353-60. PubMed ID: 6112073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate dependent stimulation of insulin and glucagon but not gastrin and somatostatin release during the intestinal phase of a meal.
    Schusdziarra V; Dangel G; Henrichs I; Klier M; Pfeiffer EF
    Horm Metab Res; 1982 Apr; 14(4):169-71. PubMed ID: 6123480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose infusion of somatostatin in man--no effect upon intestinal calcium absorption but a fall in blood insulin.
    Rümenapf G; Hanisch E; Schwille PO
    Exp Clin Endocrinol; 1986 Aug; 87(3):306-12. PubMed ID: 2877894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL; Kemmer FW; Doi K; Vranic M
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma glucagon-immunoreactive components in early life in dogs.
    Ghiglione M; Pascual JM; Rovira A; Calvo G; Valverde I
    Horm Metab Res; 1985 Aug; 17(8):387-90. PubMed ID: 2865202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.